Compare APGE & FG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APGE | FG |
|---|---|---|
| Founded | 2022 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.3B |
| IPO Year | 2023 | 2023 |
| Metric | APGE | FG |
|---|---|---|
| Price | $134.97 | $23.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $109.67 | $31.00 |
| AVG Volume (30 Days) | ★ 1.2M | 569.4K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.24 |
| Revenue | N/A | ★ $5,731,000,000.00 |
| Revenue This Year | N/A | $7.94 |
| Revenue Next Year | N/A | $5.51 |
| P/E Ratio | ★ N/A | $19.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.39 | $20.57 |
| 52 Week High | $134.99 | $35.60 |
| Indicator | APGE | FG |
|---|---|---|
| Relative Strength Index (RSI) | 77.86 | 33.80 |
| Support Level | $134.03 | $20.97 |
| Resistance Level | N/A | $29.77 |
| Average True Range (ATR) | 0.13 | 0.92 |
| MACD | -0.49 | -0.20 |
| Stochastic Oscillator | 93.56 | 26.28 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.